Corrigendum to 'IgE blockade in the management of eosinophil-associated recalcitrant pruritus due to medical tumor therapy': Annals of Oncology 2021; volume 32: 696-697.

Gutzmer, R; Sibaud, V; Hassel, J C

Gutzmer, R; Sibaud, V; Hassel, J C.

Affiliation

Gutzmer R; Skin Cancer Center Minden, Department of Dermatology, Johannes-Wesling-Klinikum Minden/Ruhr-University, Bochum, Minden, Germany. Electronic address: rgutzmer@gmx.de.
Sibaud V; Cancer University Institute, Toulouse Oncopole, Toulouse, France.
Hassel JC; Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.

Ann Oncol ; 32(10): 1310, 2021 Oct.

Article in En | MEDLINE | ID: mdl-34373158

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Ann Oncol Year: 2021 Document type: Article

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Ann Oncol Year: 2021 Document type: Article